April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Yüksel Ürün: DESTINY-Breast09 – Enhertu plus Pertuzumab Outperforms THP
Apr 23, 2025, 06:34

Yüksel Ürün: DESTINY-Breast09 – Enhertu plus Pertuzumab Outperforms THP

Yüksel Ürün, Prof. Dr. Ankara University School of Medicine, Department of Medical Oncology, shared a post on X:

“DESTINY-Breast09 shows: Enhertu + Pertuzumab > THP
  • Significant PFS benefit.
  • Consistent across all subgroups.
  • Early OS trend favoring combo.
Is this anew era in 1st-line HER2+ met. Breast cancer?”

Read Further.

Yüksel Ürün: DESTINY-Breast09 - Enhertu plus Pertuzumab Outperforms THP